NYSE · CLW

Clearwater Paper Corporation

$17.22 +$0.40 (+2.38%) 1D After hours

Key Metrics

$271.23M
Market cap
P/E · TTM
$1.54B
Revenue · TTM
−$25.10M
Net income
EPS · TTM $-1.53
Dividend yield
Free cash flow −$53.90M
Beta · 1Y 1.19
EBITDA · TTM $45.30M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 29
    The stock moved -13.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 29
  • Mar 20
    From its Feb 10 high, the share price fell 32%.

    Peak close $18.35 on Feb 10; trough close $12.44 on Mar 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%
  • Feb 19
    The stock moved -9.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$271.23M
Enterprise value$595.83M
Shares outstanding16.1M
52-wk range$11.73 – $30.02
Avg volume · 20D178.3K
Net cash −$324.60M
Book value / share$49.70
IndustryPaperboard Mills
ExchangeNYSE
About Clearwater Paper Corporation
IPO dateMay 26, 1998
Employees1263

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.18
P/FCF
EV/EBITDA13.15
EV/Sales0.39
Graham №

Profitability

Gross
Operating -3.2%
Net -1.6%
FCF -3.5%
ROE / ROIC -3.1% · —

Financial Health

Current ratio2.61
Quick ratio1.26
Debt / equity0.44
Debt / EBITDA 7.97
Net cash −$324.60M
Working capital$321.70M

Cash Flow · TTM

Operating CF $11.30M
Capex −$65.20M
Free cash flow −$53.90M
Buybacks $6.30M
Dividends paid
Shareholder yield 2.3%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

2.1
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings